The Beauty Health pany(US:SKIN)2026-03-12 21:24Financial Performance - Net sales for the year ended December 31, 2025, decreased by $33.5 million, or 10.0%, compared to 2024, with Delivery Systems net sales down by $37.3 million, or 29.8%[488] - Consumables net sales increased by $3.8 million, or 1.8%, primarily due to increased placements of Delivery Systems and price increases, despite the transition to a distributor partner in China[489] - The company reported a net loss of $9.5 million, or 3.2% of net sales, compared to a net loss of $29.1 million, or 8.7% in 2024[486] Cost and Expenses - Cost of sales decreased by $47.6 million, or 31.3%, leading to a gross profit increase of $14.1 million, or 7.7%, and a gross margin improvement to 65.3% from 54.5%[490] - Selling and marketing expenses decreased by $24.7 million, or 20.9%, as a percentage of net sales fell to 31.1% from 35.4%[491] - Research and development expenses decreased by $0.7 million, or 10.6%, remaining at 1.9% of net sales[492] - Total operating expenses were $217.2 million, or 72.2% of net sales, compared to $250.1 million, or 74.8% in 2024[487] - General and administrative expenses decreased by $7.5 million, or 6.0%, to $117.9 million in 2025 from $125.5 million in 2024, primarily due to lower personnel-related expenses[493] Interest and Financing - Interest expense increased to $19.3 million, or 6.4% of net sales, from $10.4 million, or 3.1% in 2024[487] - Interest expense increased by $8.9 million, or 85.6%, to $19.3 million in 2025 compared to $10.4 million in 2024, mainly due to interest and amortization of debt issuance costs related to the 2028 Notes[494] - Interest income decreased by $7.7 million, or 46.2%, to $(9.0) million in 2025 from $(16.6) million in 2024, primarily due to lower average invested balances[495] Cash Flow and Liquidity - The company had cash, cash equivalents, and restricted cash of $232.7 million as of December 31, 2025, down from $370.1 million at the beginning of the year[498] - Net cash provided by operating activities was $37.5 million in 2025, compared to $16.1 million in 2024, reflecting improved operational efficiency[516] - Net cash provided by operating activities for the year ended December 31, 2025 was $37.5 million, up from $16.1 million in 2024, primarily due to changes in working capital and non-cash adjustments[517] - Net cash used for investing activities decreased to $5.2 million in 2025 from $6.8 million in 2024, attributed to lower capital expenditures[518] - Net cash used for financing activities increased to $174.9 million in 2025 from $158.3 million in 2024, mainly related to the exchange and repurchases of the Company's 2026 Notes[519] Market and Economic Conditions - The company transitioned sales in the China market to a distributor partner, discontinuing direct sales to customers in that region[475] - The company remains vigilant regarding economic and geopolitical conditions that may impact future performance and is implementing risk mitigation strategies[471] - The Company continues to face macroeconomic challenges that could adversely impact revenues and earnings going forward[511] - Inflation has adversely affected the Company's liquidity and overall cost structure, with expectations of continued cost increases if inflation persists[541] Foreign Currency and Interest Rate Risks - An adverse 10% foreign currency exchange rate change would have resulted in an adverse effect on income before income taxes of approximately $4 million and $6 million for the years ended December 31, 2025 and 2024, respectively[538] - A hypothetical 100 basis points increase in interest rates would have resulted in an increase in the fair market value of the investment portfolio by approximately $1 million and $3 million as of December 31, 2025 and 2024, respectively[536] - The Company has not engaged in the hedging of foreign currency transactions to date, although it may consider doing so in the future[539] Inventory and Revenue Recognition - The Company recognized revenue of approximately $17 million for the year ended December 31, 2023 from the estimated fair value of refurbished Delivery Systems, with no trade-in revenue recognized for 2025 and 2024[521] - The Company experienced approximately $7 million of inventory charges related to the write-down of trade-in Delivery Systems to its net realizable value during the year ended December 31, 2024[522] - Total contractual obligations as of December 31, 2025, amounted to $471.6 million, with $124.5 million due within one year[514] - The Company does not rely on projected income to support the realization of deferred tax assets due to cumulative pre-tax losses as of December 31, 2025[531]